文献速递外周动脉疾病

急性及亚急性下肢缺血机械减容初始治疗的一年结果

Prospective Single-Arm Trial of Endovascular Mechanical Debulking as Initial Therapy in Patients With Acute and Subacute Lower Limb Ischemia: One-Year Outcomes.
PubMed 文献 · J Endovasc Ther · 2019-04-06

这项前瞻性单臂研究纳入316例急性或亚急性下肢缺血患者,以血管内机械减容作为初始治疗,总体技术成功率达100%,30天一期和二期通畅率分别为94.3%和97.2%,1年无截肢生存率估计为87.4%。

要点

  • 机械减容联合辅助技术可实现靶病变100%技术成功。
  • 30天死亡率0.3%,严重并发症发生率3.5%。
  • 1年无截肢生存率估计为87.4%。

核心结论

  • 机械减容单独或联合辅助技术可作为急性或亚急性下肢缺血患者膝上血管闭塞的初始治疗。

研究设计与样本

  • 前瞻性单臂研究,2009年4月至2015年4月连续纳入316例急性或亚急性下肢缺血患者,平均年龄70.9±12岁,男性184例。

主要发现

  • 靶病变总体技术成功(残余狭窄≤30%)为100%。
  • 30天一期和二期通畅率分别为94.3%和97.2%,死亡率为0.3%。
  • 229例符合1年随访条件的患者中,199例有可用数据,无截肢生存率估计为87.4%。

关键数值与推荐

  • 急性缺血组中IIb类缺血146例(72.3%),IIa类56例(27.7%)。
  • 亚急性缺血组中 critical limb ischemia 诊断74例(64.9%)。
  • 靶闭塞长度平均22.9±14.8 cm,血栓性256例,栓塞性60例。

临床怎么用

  • 对于膝上血管闭塞的急性或亚急性下肢缺血,可考虑机械减容作为初始治疗以避免溶栓或开放手术风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To report the results of a prospective, single-arm study to establish whether the initial treatment of acute or subacute limb ischemia (ALI and SLI, respectively) can be accomplished successfully using endovascular mechanical debulking of the target vessels to avoid the risks associated with thrombolysis and/or open surgery. MATERIALS AND METHODS: From April 2009 to April 2015, 316 consecutive patients (mean age 70.9±12 years; 184 men) with ALI (202, 63.9%) or SLI (114, 36.1%) were enrolled; the only exclusion criterion was irreversible ischemia. The ALI group included 146 (72.3%) participants with category IIb ischemia and 56 (27.7%) with category IIa. Critical limb ischemia was diagnosed in 74 (64.9%) of the 114 patients with SLI. Target occlusions of thrombotic (n=256) or embolic (n=60) origin were located in the femoropopliteal segment (n=231), prosthetic or venous femoropopliteal bypass grafts (n=75), and the aortoiliac segment (n=35). The mean occlusion length was 22.9±14.8 cm. RESULTS: The overall technical success (residual stenosis ≤30%) was 100% after debulking and adjunctive techniques (aspiration, dilation, stenting) at the level of the target lesions. No open surgical or thrombolytic modalities were necessary to bypass or recanalize the target vessels, and no death occurred in association with target occlusion therapy. Additional infrapopliteal interventions were performed in 195 (61.7%) patients (adjunctive thrombolysis in 29) to treat acute, subacute, and chronic lesions. Minor complications directly related to the debulking procedure occurred in 26 (8.2%) patients. Serious complications occurred in 11 (3.5%) patients, including hemorrhage in 8 (2.5%) patients (associated with infrapopliteal thrombolysis in 5). At 30 days, primary and secondary patency rates were 94.3% and 97.2%, respectively; mortality was 0.3% (1 fatal intracranial hemorrhage after adjunctive thrombolysis). Of 229 patients eligible for 1-year follow-up, amputation-free survival was estimated to be 87.4% in 199 patients with available data. CONCLUSION: In this all-comers study, mechanical debulking with the Rotarex alone or with adjunctive techniques is feasible as a primary therapy for occluded supratibial vessels in patients with ALI or SLI.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Bulvas M, Sommerová Z, Vaněk I, et al. Prospective Single-Arm Trial of Endovascular Mechanical Debulking as Initial Therapy in Patients With Acute and Subacute Lower Limb Ischemia: One-Year Outcomes. J Endovasc Ther. 2019. PMID: 30955402. doi:10.1177/1526602819840697

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。